Clinical Research Facility

Catonsville, Maryland 21228

We've found

1 trials

at this facility

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Catonsville, MD

Use our guide to learn which trials are right for you!